Skip to content

A Clinical Study on the management of Bronchial Asthma

A Clinical Study on the Efficacy of Mahaswasari Loham in Tamaka Swasa with special reference to Bronchial Asthma - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074674
Enrollment
30
Registered
2024-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J453- Mild persistent asthma

Interventions

None listed

Sponsors

Dr Kummari Nikhitha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Who are willing to participate in the study and agree for the consent sign 2.symptoms exacerbations cough, wheeze, dyspnea greater than a week 3.Mild persistant cases of asthma of duration more than 6months 4.Night symptoms twice per month but less than twice per week 5.FEVI greater than 80% 6.spo2 greater than 92% 7.Non smokers

Exclusion criteria

Exclusion criteria: 1.Moderate and severe persistent asthma 2.Asthma due to other systemic origin 3.suffering from diabetes,cardiac asthma, status asthmatics,CVDs, autoimmune disorders. 4.HIV positive cases,pregnant women, lactating mothers 5.patients who need salbutamol inhaler daily 6.dyspnea due to other diseases like COPD, bronchiectasis, pulmonary tuberculosis, interstitial lung disease, occupational lung disease, malignancies.

Design outcomes

Primary

MeasureTime frame
To reduce the frequency of episodes of Shortness of breathTimepoint: 60 days

Secondary

MeasureTime frame
to reduce the signs and symptoms of bronchial AsthmaTimepoint: 60 days

Countries

India

Contacts

Public ContactDr K Laxmikantham

Dr. BRKR Govt Ayurvedic Medical College and Hospital

drlaxmikantham20@gmail.com9989398463

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026